Product Information

BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Somerset Therapeutics, LLC, priced at $9.1795 per ML under NDC 70069056701. Its NADAC has been published 98 times since Jan 1, 2025.

FDA first approved this application on Aug 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE TARTRATE 0.1% DROP

BRIMONIDINE TARTRATE
$9.1795per ML

Strength

1 mg/mL

NDC

70069056701

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216906

FDA Approved

8/9/2024

TE Code

AB

On Market Since

8/26/2024

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 98 times since Jan 1, 2025, and over the history we have for it it has declined 50.3%. The table below summarizes its recorded NADAC range and movement.

Current price$9.1795 per ML
All-time high$18.4829 (Jan 15, 2025)
All-time low$9.1795 (Oct 21, 2026)
52-week high$14.2530
52-week low$9.1795
Median price$14.2530
Average price$13.9024
Largest weekly change-12.7% (Oct 21, 2026)
Weeks tracked98
Tracking sinceJan 1, 2025

Price History

1W

0.0%

1M

-12.7%

3M

-14.2%

6M

-17.5%

1Y

-43.6%

3Y

N/A

5Y

N/A

All

-50.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 34%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Somerset Therapeutics, LLC, is $9.1795 per ML (NDC 70069056701), effective Nov 11, 2026.

How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 50.3%. It has been tracked across 98 weekly CMS publications since Jan 1, 2025.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?

Since Jan 1, 2025, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $9.1795 (Oct 21, 2026) to a high of $18.4829 (Jan 15, 2025), with a median of $14.2530 per ML.

Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $6.0954 per ML — about 34% below BRIMONIDINE TARTRATE 0.1% DROP.

Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?

BRIMONIDINE TARTRATE 0.1% DROP (NDC 70069056701) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.